Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene

Circulation

Volumn 93, Issue 1, 1996, Pages 10-17

  Zoldhelyi, Pierre ^a   McNatt, Janice ^a   Xu, Xiao Ming ^a   Loose Mitchell, David ^a   Meidell, Robert S ^b   Clubb Jr , Fred J ^c   Buja, L Maximilian ^a,c   Willerson, James T ^a,c   Wu, Kenneth K ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TEXAS HEART INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

angioplasty; gene transfer; prostaglandins; thrombosis

Indexed keywords

PROSTACYCLIN; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTERY THROMBOSIS; ARTICLE; ATHEROGENESIS; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; CORONARY ARTERY DILATATION; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; THROMBOCYTE AGGREGATION;

EID: 0030069454     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.1.10     Document Type: Article

References (35)

1. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-665.
2. Vane JR. Prostaglandins and the cardiovascular system. Br Heart J. 1983;49:405-409.
3. Pomerantz K, Hajjar D. Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. Arteriosclerosis. 1989;9:413-429.
4. Wu KK, Kulmacz RJ, Wang L-H, Loose-Mitchell DS, Tsai A-L. Molecular biology of prostacyclin biosynthesis. In: Rubanyi G, Vane JR, eds. Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications. Amsterdam, Netherlands: Elsevier Science Publishers BV; 1992:11-23.
5. Szczeklik A, Nizankowski R, Skawinski S, Szczeklik J, Gluszko P, Gryglewski RJ. Successful therapy of advanced atherosclerosis obliterans with prostacyclin. Lancet. 1979;1:1111-1114.
6. Belch JJF, Newman P, Drury JK, McKenzie F, Capell H, Leiberman P, Forbes CD, Prentice CRM. Intermittent prostacyclin infusion in patients with Raynaud's syndrome. Lancet. 1983;1: 313-315.
7. Sanduja SK, Tsai A-L, Matijevic-Aleksic N, Wu KK. Kinetics of prostacyclin synthesis in a PGHS-1 overexpressed endothelial cell. Am J Physiol. 1994;267:C1459-C1466.
8. Kent RS, Diedrich SL, Whorton R. Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta. J Clin Invest. 1983;72:455-465.
9. 2 in response to histamine, bradykinin and ATP. J Clin Invest. 1985;76:271-280.
10. Xu X-M, Ohashi K, Sanduja SK, Ruan K-H, Wang L-H, Wu KK. Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA. J Clin Invest. 1993;91:1843-1849.
11. Flugelman MY, Jaklitsch MT, Newman KD, Casscells SW, Brattauer GL, Dichek DA. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation. 1992;85:1110-1117.
12. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73:797-807.
13. Gomez-Foix AM, Coats WS, Baque S, Alam T, Gerard RD, Newgard CB. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem. 1992;267:25129-25134.
14. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA. 1993;980:2812-2816.
15. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA. 1983;80:3734-3738.
16. Ross R. The smooth muscle cell, II: growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971;50:172-186.
17. Wu KK, Sanduja R, Ferhanoglu B, Loose-Mitchell DS. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc Natl Acad Sci USA. 1991;88: 2384-2387.
18. Butler KD, Ambler J, Dolan S, Giddings J, Talbot MD, Wallis RB. A non-occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity. Blood Coagul Fibrinolysis. 1992;3:155-165.
19. Steele PM, Chesebro JH, Stanson AW, Holmes DR, Dewanjee MK, Badimon K, Fuster V. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res. 1985;57:105-112.
20. Willerson JT, Yao GK, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, Buja LM. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci USA. 1991;88: 10624-10628.
21. Willard JE, Landau C, Glamann DB, Burns D, Jessen ME, Pirwitz MJ, Gerard RD, Meidell RS. Genetic modification of the vessel wall: comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 1994;89:2190-2197.
22. Coughlin SR, Moskowitz MA, Zetter BR, Antoniades HN, Levine L. Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature. 1980;288:600-602.
23. Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kaski JC. Angiographic stenosis progression and coronary events in patients with 'stabilized unstable angina.' Circulation. 1995;91:2319-2324.
24. Duguid JB. Mural thrombosis in arteries. Br Med Bull. 1955;11: 36-38.
25. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation. 1985;71:699-708.
26. Eichhorn EJ, Grayburn PA, Willard JE, Anderson HV, Bedotto JB, Carry M, Kahn JK, Willerson JT. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol. 1991;17:43-52.
27. Anderson HV, Kirkeeide RL, Krishnaswami A, Weigelt LA, Revana M, Weisman HF, Willerson JT. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. J Am Coll Cardiol. 1994;23:1031-1037.
28. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Bio Chem. 1993;268:9049-9054.
29. Pritchard KA Jr, O'Banion MK, Miano JM, Vlasic N, Bhatia UG, Young DA, Stemerman MB. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem. 1994; 269:8504-8509.
30. Conary JT, Parker RE, Christman BW, Faulks RD, King GA, Meyrick BO, Brigham KL. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. J Clin Invest. 1994;93:1834-1840.
31. Feldman LJ, Steg PG, Zheng LP, Chen D, Kearney M, McGarr SE, Barry JJ, Dedieu J-F, Perricaudet M, Isner JM. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest. 1995;95:2662-2671.
32. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 1994;91:6196-6200.
33. Bout A, Perricaudet M, Baskin G, Imver JL, Scholte BJ, Pavirani A, Valerio D. Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum Gene Ther. 1994;5:3-10.
34. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 1993;72:1132-1138.
35. Schulick AH, Newman KD, Virmani R, Dichek DA. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation. 1995;91:2407-2414.